32 Stocks Moving In Monday’s Mid-Day Session
Gainers
Nuvectis Pharma, Inc. (NASDAQ: NVCT) jumped 191.2% to $9.47. The company, on Friday, priced its IPO at $5 per share.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 152 companies set new 52-week lows.
Statera Biopharma Submits Phase 3 Clinical Trial Protocol To FDA For Investigational Treatment Of Pediatric Crohn’s Disease
Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced submission to the U.S.
Statera Biopharma Reports First Patient Dosed In STAT-205 Study For Acute COVID
Initial Study to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205
Targeting Preliminary Data 2022
FORT COLLINS, Colo., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma (NASDAQ:STAB), a leading